Appling County v. Endo Health Solutions, Inc. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:20-op-45081 |
| Nature of Suit | 360 Torts - Personal Injury - Other Personal Injury |
| Cause | 28:1332 Diversity-Racketeering (RICO) Act |
| Case Filed: | Feb 24, 2020 |
| Last checked: Tuesday Mar 17, 2020 2:28 PM EDT |
|
Defendant
Rite Aid Corporation
|
|
|
Defendant
Kroger Limited Partnership II
|
|
|
Defendant
Mallinckrodt LLC
|
|
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
McKesson Corporation
|
|
|
Defendant
Mylan N.V.
|
|
|
Defendant
Mylan Pharmaceuticals, Inc.
|
|
|
Defendant
Noramco, Inc.
|
|
|
Defendant
Novartis AG
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Par Pharmaceutical Companies, Inc.
|
|
|
Defendant
Par Pharmaceutical, Inc.
|
|
|
Defendant
Kroger Limited Partnership I
|
|
|
Defendant
Rite Aid of Maryland, Inc. d/b/a Rite Aid Mid-Atlantic Customer Support Center
|
|
|
Defendant
Sandoz, Inc.
|
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
TEVA Pharmaceuticals USA, Inc.
|
|
|
Defendant
Teva Pharmaceutical Industries, Ltd.
|
|
|
Defendant
The Kroger Co.
|
|
|
Defendant
Wal-Mart Stores East, LP
|
|
|
Defendant
Walgreen Co.
50 West Broad St., Suite 1330
Columbus, OH 43215 |
|
|
Defendant
Walmart Inc.
|
|
|
Defendant
Watson Laboratories, Inc.
|
|
|
Defendant
West-Ward Pharmaceuticals Corp. n/k/a Hikma Pharmaceuticals USA Inc.
|
|
|
Defendant
Cardinal Health, Inc.
|
|
|
Defendant
Actavis LLC
|
|
|
Defendant
Actavis Pharma, Inc. f/k/a Watson Pharma, Inc.
|
|
|
Defendant
Allergan Finance, LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Allergan PLC f/k/a Actavis PLC
|
|
|
Defendant
AmerisourceBergen Drug Corporation
|
|
|
Defendant
Amneal Pharmaceuticals, Inc.
|
|
|
Defendant
Amneal Pharmaceuticals, LLC
|
|
|
Defendant
Anda, Inc.
|
|
|
Defendant
CVS Health Corporation
|
|
|
Defendant
CVS TN DISTRIBUTION, LLC
|
|
|
Defendant
Cephalon, Inc.
|
|
|
Defendant
Eckerd Corporation
|
|
|
Defendant
Endo Health Solutions, Inc.
|
|
|
Defendant
Endo Pharmaceuticals, Inc.
|
|
|
Defendant
Harco, Inc. f/k/a Harco Drug, Inc.
|
|
|
Defendant
Hikma Pharmaceuticals PLC
|
|
|
Defendant
J M Smith Corporation
|
|
|
Defendant
Janssen Pharmaceutica, Inc. n/k/a Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Johnson & Johnson
|
|
|
Plaintiff
Appling County
|
Represented By
|
| Docket last updated: 03/17/2020 2:26 PM EDT |
| Monday, February 24, 2020 | ||
| 1 | 1
255
pgs
Complaint with jury demand against Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., Allergan Finance, LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc., Allergan PLC f/k/a Actavis PLC, AmerisourceBergen Drug Corporation, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals, LLC, Anda, Inc., CVS Health Corporation, CVS TN DISTRIBUTION, LLC, Cardinal Health, Inc., Cephalon, Inc., Eckerd Corporation, Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., Harco, Inc. f/k/a Harco Drug, Inc., Hikma Pharmaceuticals PLC, J M Smith Corporation, Janssen Pharmaceutica, Inc. n/k/a Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Kroger Limited Partnership I, Kroger Limited Partnership II, Mallinckrodt LLC, Mallinckrodt PLC, McKesson Corporation, Mylan N.V., Mylan Pharmaceuticals, Inc., Noramco, Inc., Novartis AG, Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc., Par Pharmaceutical, Inc., Rite Aid Corporation, Rite Aid of Maryland, Inc. d/b/a Rite Aid Mid-Atlantic Customer Support Center, Sandoz, Inc., SpecGX LLC, TEVA Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., The Kroger Co., Wal-Mart Stores East, LP, Walgreen Co., Walmart Inc., Watson Laboratories, Inc., West-Ward Pharmaceuticals Corp. n/k/a Hikma Pharmaceuticals USA Inc.. Filing fee paid $ 400, Receipt number AOHNDC-9814189.. Filed by Appling County. (Schramm, Sara)
|
|
|
Att: 1
Brief in Support
|
||